Skip to main content

Infigratinib Phosphate

Placeholder slot
 (IN-fig-RA-tih-nib FOS-fayt)

This page contains brief information about infigratinib phosphate and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Truseltiq
FDA Approved
Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Infigratinib phosphate is approved to treat:

Infigratinib phosphate is approved under FDA’s Accelerated Approval Program. As a condition of approval, confirmatory trial(s) must show that it provides a clinical benefit in these patients.

Infigratinib phosphate is also being studied in the treatment of other types of cancer.

More About Infigratinib Phosphate

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Targeted Cancer Therapies

Clinical Trials Accepting Patients

Find Clinical Trials for Infigratinib Phosphate - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: